Galenica Posts Growth in Nine-month Group Net Sales; FY26 Outlook Affirmed

MT Newswires · 2d ago
01:06 AM EDT, 10/22/2026 (MT Newswires) -- Galenica (GALE.SW) logged a year-over-year growth in group net sales for the first nine months of 2026, a Thursday filing showed. For the nine months ended Sept. 30, group net sales stood at 3.17 billion francs versus 3 billion francs previously, the Swiss pharmaceutical and logistics company added. For full-year 2026, the company reiterated its sales growth guidance of between 5% and 7%. The company also plans to pay a dividend at least similar to the 2025 level.